Are you Dr. Halpern?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 57 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 206-606-1025- Is this information wrong?
Summary
- Dr. Anna Halpern, MD is an oncologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Illinois. She is affiliated with Fred Hutchinson Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2013 - 2016
University of ChicagoResidency, Internal Medicine, 2009 - 2012
The Warren Alpert Medical School of Brown UniversityClass of 2009
Certifications & Licensure
WA State Medical License 2013 - 2024
IL State Medical License 2009 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Start of enrollment: 2016 Dec 01
- Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm Start of enrollment: 2016 Dec 30
Publications & Presentations
PubMed
- Time independent factors that predict relapse in adults with acute myeloid leukemia.Lim, J., Othus, M., Shaw, C., Russell, K., Estey, E., Halpern, A., Appelbaum, J., Hendrie, P., Walter, R., Percival, M.> ;Blood Cancer Journal. 2024 Jan 15
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob S App...> ;Blood Advances. 2023 Sep 12
- 2 citationsInvasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms.Julian Lindsay, Carla S Walti, Anna B Halpern, Hu Xie, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Matth...> ;Blood Advances. 2023 Jul 11
- Join now to see all
Press Mentions
Sorafenib plus GCLAM Held Safe in AML, MDS Phase-1 StudyApril 22nd, 2019
iHealthHome Supports Cancer Researchers on Home Telemonitoring Study of Leukemia PatientsDecember 1st, 2017
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
